Literature DB >> 18372004

Carcinogenesis and aging 20 years after: escaping horizon.

Vladimir N Anisimov1.   

Abstract

Carcinogenesis is a multistage process: neoplastic transformation implies the engagement of a cell through sequential stages, and different agents may affect the transition between continuous stages. Multistage carcinogenesis is accompanied by disturbances in tissue homeostasis and perturbations in nervous, hormonal, and metabolic factors which may affect antitumor resistance. The development of these changes depends on the susceptibility of various systems to a carcinogen and on the dose of the carcinogen. Changes in the microenvironment may condition key carcinogenic events and determine the duration of each carcinogenic stage, and sometimes they may even reverse the process of carcinogenesis. These microenvironmental changes influence the proliferation rate of transformed cells, the total duration of carcinogenesis and, consequently, the latent period of tumor development. Aging may increase or decrease the susceptibility of various tissues to initiation of carcinogenesis and usually facilitates promotion and progression of carcinogenesis. Aging may predispose to cancer by two mechanisms: tissue accumulation of cells in late stages of carcinogenesis and alterations in internal homeostasis, in particular, alterations in immune and endocrine system. Aging is associated with number of events at molecular, cellular and physiological levels that influence carcinogenesis and subsequent cancer growth.

Entities:  

Mesh:

Year:  2008        PMID: 18372004     DOI: 10.1016/j.mad.2008.02.004

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  14 in total

Review 1.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 2.  How ageing processes influence cancer.

Authors:  João Pedro de Magalhães
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

3.  Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in young but not in old rats.

Authors:  Irina A Vinogradova; Vladimir N Anisimov; Andrey V Bukalev; Viktor A Ilyukha; Evgeniy A Khizhkin; Tatiana A Lotosh; Anna V Semenchenko; Mark A Zabezhinski
Journal:  Aging (Albany NY)       Date:  2010-03-20       Impact factor: 5.682

4.  Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes.

Authors:  Rong Wang; Cary P Gross; Stephanie Halene; Xiaomei Ma
Journal:  Leuk Res       Date:  2009-03-25       Impact factor: 3.156

5.  Intrinsic Versus Extrinsic Cancer Risk Factors and Aging.

Authors:  Dmitriy I Podolskiy; Vadim N Gladyshev
Journal:  Trends Mol Med       Date:  2016-08-17       Impact factor: 11.951

Review 6.  Metformin: do we finally have an anti-aging drug?

Authors:  Vladimir N Anisimov
Journal:  Cell Cycle       Date:  2013-10-24       Impact factor: 4.534

Review 7.  Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?

Authors:  Curtis J Henry; Andriy Marusyk; James DeGregori
Journal:  Aging (Albany NY)       Date:  2011-06       Impact factor: 5.682

8.  Reversing the aging stromal phenotype prevents carcinoma initiation.

Authors:  Davina A Lewis; Jeffrey B Travers; Christiane Machado; Ally-Khan Somani; Dan F Spandau
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

Review 9.  Metformin for aging and cancer prevention.

Authors:  Vladimir N Anisimov
Journal:  Aging (Albany NY)       Date:  2010-11       Impact factor: 5.682

10.  Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging.

Authors:  Michelle Farazi; Justine Nguyen; Josef Goldufsky; Stephanie Linnane; Lisa Lukaesko; Andrew D Weinberg; Carl E Ruby
Journal:  Cancer Immunol Immunother       Date:  2014-03-30       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.